Variables | PIM users | PIM non-users | COR [95%CI] | p-value | AOR [95%CI] | p-value | |
---|---|---|---|---|---|---|---|
Age, year | 70 (IQR = 9) | 67 (IQR = 5) | 1.15 [1.06, 1.26] | <  0.00 | 1.21 [1.09, 1.34] | <  0.001 | |
Sex | Male | 118 (64.8% | 25 (67.6%) | 0.89 [0.42, 1.88] | 0.75 | – |  |
 | Female | 64 (35.2%) | 12 (32.4%) | 1 |  |  |  |
Residence | Urban | 91 (50.0%) | 15 (40.5%) | 1.47 [0.72, 3.01] | 0.29 | – |  |
 | Rural | 91 (50.0%) | 22 (59.5%) | 1 |  |  |  |
Outpatient visits in the last 06 months |  |  |  |  |  |  |  |
1–2 times | 23 (12.6%) | 11 (29.7%) | 1 |  | 1 |  | |
3 times | 81 (44.5%) | 18 (48.7%) | 2.15 [0.89, 5.19] | 0.09 | 2.55 [0.80, 8.14] | 0.11 | |
4 times | 33 (18.1%) | 4 (10.8%) | 3.95[1.11, 13.94] | 0.03 | 3.48 [0.69, 17.52] | 0.13 | |
5 times | 16 (8.8%) | 2 (5.4%) | 3.83 [0.75, 19.65] | 0.11 | 3.53 [0.48, 26.05] | 0.22 | |
6 times | 29 (15.9%) | 2 (5.4%) | 6.94 [1.39, 34.45] | 0.02 | 5.07 [0.74, 34.71] | 0.09 | |
Number of chronic diseases | Â | Â | Â | Â | Â | Â | Â |
One | 59 (32.4%) | 22 (59.5%) | 1 | Â | 1 | Â | |
Two | 89 (48.9%) | 8 (21.6%) | 0.55 [0.21, 1.43] | 0.22 | 2.70 [0.85, 8.61] | 0.09 | |
≥ Three | 34 (18.7%) | 7 (18.9%) | 2.29 [0.77, 6.80] | 0.14 | 1.46 [0.29, 7.28] | 0.65 | |
Hypertension | Yes | 117 (64.3%) | 10 (27.0%) | 4.86 [2.21, 10.67] | <  0.00 | 4.17 [1.51, 11.56] | <  0.001 |
 | No | 65 (35.7%) | 27 (73.0%) | 1 |  | 1 |  |
Diabetes mellitus | Yes | 60 (33.0%) | 9 (24.3%) | 1.53 [0.68, 3.45] | 0.31 | Â | Â |
 | No | 122 (67.0%) | 28 (75.7%) | 1 |  |  |  |
Ischemic heart disease | Yes | 26 (14.3%) | 4 (10.8%) | 1.35 [0.45, 4.20] | 0.58 | Â | Â |
No | 156 (85.7%) | 33 (89.2%) | 1 | Â | Â | Â | |
Ischemic stroke | Yes | 15 (8.2%) | 6 (16.2%) | 0.46 [0.17, 1.29] | 0.14 | 0.133 [0.03, 0.64] | 0.01 |
 | No | 167 (91.8%) | 31 (83.8%) | 1 |  | 1 |  |
Asthma | Yes | 4 (2.2%) | 4 (10.8%) | 0.19 [0.04, 0.78] | 0.02 | 0.03 [0.00, 0.39] | <  0.001 |
 | No | 178 (97.8%) | 33 (89.2%) | 1 |  | 1 |  |
Heart failure | Yes | 15 (8.2%) | 1 (2.7%) | 3.23 [0.41, 25.27] | 0.26 | Â | Â |
 | No | 167 (91.8%) | 36 (97.3%) | 1 |  |  |  |
Hypertensive heart disease | Yes | 11 (6.0%) | 4 (10.8%) | 0.53 [0.16, 1.77] | 0.53 | Â | Â |
No | 171 (94.0%) | 33 (89.2%) | 1 | Â | Â | Â | |
Peripheral neuropathy | Yes | 25 (13.7%) | 0 | Â | 0.99 | Â | Â |
No | 157 (86.3%) | 37 (100.0%) | 1 | Â | Â | Â | |
Epilepsy | Yes | 7 (3.9%) | 6 (16.2%) | 0.21 [0.07, 0.66] | <  0.00 | 0.42 [0.09, 2.08] | 0.29 |
 | No | 175 (96.1%) | 31 (83.8%) | 1 |  | 1 |  |
Chronic obstructive pulmonary disease | Yes | 5 (2.8%) | 2 (5.4%) | 0.49 [0.09, 2.65] | 0.41 | Â | Â |
No | 177 (97.2%) | 35 (94.6%) | 1 | Â | Â | Â | |
Dyspepsia | Yes | 6 (3.3%) | 1 (2.7%) | 1.23 [0.14, 10.51] | 0.85 | Â | Â |
 | No | 176 (96.7%) | 36 (97.3%) | 1 |  |  |  |
Ischemic dilated cardiomyopathy | Yes | 14 (7.7%) | 1 (2.7%) | 3.0 [0.38, 23.55] | 0.29 | Â | Â |
No | 168 (92.3%) | 36 (97.3%) | 1 | Â | Â | Â | |
Atrial fibrillation | Yes | 7 (3.8%) | 1 (2.7%) | 1.44 [0.17, 12.07] | 0.74 | Â | Â |
No | 175 (96.2%) | 36 (97.3%) | 1 | Â | Â | Â | |
Polypharmacy | ≥ 5 drugs | 89 (48.9%) | 4 (10.8%) | 7.89 [2.69, 23.19] | <  0.00 | 14.10 [2.61, 76.38] | <  0.001 |
 | <  5 drugs | 93 (51.1%) | 33 (89.2%) | 1 |  | 1 |  |